Results 91 to 100 of about 3,726 (180)

In Reference to the Original Article “Three Calcium Hydroxyapatite‐Based Dermal Fillers Marketed in Mexico: Comparison of Particle Size and Shape Using Electron Microscopy”

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
Gilberto Antonio Sanchez Rico
wiley   +1 more source

Achieving Rapid Remission With Guselkumab in a Moderately Active Ulcerative Colitis Patient With High Infectious Risk and Inadequate Response to Advanced Therapy: A Case Report. [PDF]

Cureus
Furuichi N, Itoi Y, Oshima K, Takeuchi Y, Uraoka T.   +4 more
europepmc   +1 more source

Efficacy and Safety of Guselkumab in Real-World Evidence: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Dodero-Anillo JM, Fernandez-Pujol-Marzo M, Martinez MJP, Ruiz-Villaverde R, Armario-Hita JC.   +4 more
europepmc   +1 more source

A Rapid and Marked Response to Guselkumab in Extensive Plaque Psoriasis: A Case Report. [PDF]

Cureus
Oropesa E, Aguila YL, Pena Reina BD, Vargas Batista ID, Pereda Gonzalez Y, Milanes Chongon MD.   +5 more
europepmc   +1 more source

Multiomic characterisation of the clinical efficacy of guselkumab induction therapy in ulcerative colitis. [PDF]

BMJ Open Gastroenterol
Hart A, Sridhar S, Venkat S, Lee T, Rusbuldt JJ, Richards D, Sisk C, Horowitz D, Tomsho L, Kannan AK, Ruane D, Van den Berge K, Rubin DT, Sands BE, De Hertogh G, Huang KG, Germinaro M, Cua D, Waterworth D, Freeman TC, Vetter ML, McRae B, Verstockt B, Branigan P.   +23 more
europepmc   +1 more source

Case Report: Upadacitinib and apremilast combination therapy for guselkumab-induced paradoxical eczema in psoriasis. [PDF]

Front Immunol
Yang L, Zhou J, Ruan Z, Shi K.
europepmc   +1 more source

Interleukin-23 Inhibitors in Inflammatory Bowel Disease. [PDF]

BioDrugs
Puca P, Parello S, Colantuono S, Tursi A, Coppola G, Lopetuso LR, Scaldaferri F, Gasbarrini A, Papa A.   +8 more
europepmc   +1 more source

First-Line Guselkumab Combined with Exclusive Enteral Nutrition in Biologic-Naïve Young‑Onset Crohn's Disease: A Three-Case Series from China. [PDF]

J Inflamm Res
Sha S, Xu B, Qiao C, Wang K, Liu L, Wu J, Ma W, Shi A, Liu X.   +8 more
europepmc   +1 more source

Comparative Effectiveness of Four Biologics for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis. [PDF]

Cureus
Abdullah A, Polus L.
europepmc   +1 more source

Systemic Immune-Inflammation Index and Systemic Inflammation Response Index in Psoriasis: Limited Utility for Monitoring Response to IL-23 Inhibitors. [PDF]

Dermatol Pract Concept
Bardazzi F, Natale A, Maltoni L, Clarizio G, Brunetti T, Cafasso G, Sacchelli L, Loi C, Piraccini BM, Cedirian S.   +9 more
europepmc   +1 more source